MiNA Therapeutics

MiNA Therapeutics is a pioneering biotechnology company dedicated to developing innovative medicines that restore normal cellular function. By harnessing an innate mechanism of gene activation, MiNA Therapeutics is transforming the therapy landscape for severe liver diseases and other critical illnesses. MiNA Therapeutics' proprietary platform and deep clinical expertise drive the creation of novel RNA therapeutics that address unmet medical needs.

Located at Translation & Innovation Hub, 80 Wood Lane, London, W12 0BZ, GB, MiNA Therapeutics is committed to advancing the boundaries of medical science. The company's focus on gene activation and RNA therapeutics positions it as a leader in the next generation of drug discovery and development.

MiNA Therapeutics strives to make a significant impact on global healthcare. The company’s dedication to innovation and patient well-being is at the heart of its mission. We invite the management team at MiNA Therapeutics to create a customized and exclusive company showcase and product listing on our platform to further highlight your groundbreaking work.